A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma (Q33395607)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma
scientific article

    Statements

    A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit